Literature DB >> 16365261

Relationship between smoking and the clinical severity of psoriasis.

Cristina Fortes1, Simona Mastroeni, Karen Leffondré, Francesca Sampogna, Franco Melchi, Eva Mazzotti, Paolo Pasquini, Damiano Abeni.   

Abstract

OBJECTIVE: To evaluate the association between different components of smoking history and the clinical severity of psoriasis.
DESIGN: A hospital-based cross-sectional study.
SETTING: Inpatient wards of a hospital for skin diseases in Rome, Italy. PATIENTS: A total of 818 adults with psoriasis. MAIN OUTCOME MEASURE: The Psoriasis Area and Severity Index was used to assess the clinical severity of psoriasis between February 21, 2000, and February 19, 2002.
RESULTS: After adjustment for potential confounders (sex, age, body mass index, psychological distress, family history of psoriasis, duration of psoriasis disease, and alcohol consumption), high intensity of smoking (>20 cigarettes daily) vs a lower level of consumption (< or =10 cigarettes daily) was associated with a more than 2-fold increased risk of clinically more severe psoriasis (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.2-4.1). Cigarette-years, measured as the product of the intensity and duration (years) of smoking, significantly increased the risk of clinically more severe psoriasis after adjustment for confounding factors (OR,1.3; 95% CI, 1.0-1.6, for a 600-U increase in cigarette-years). Separate analyses for men and women showed that the effect of cigarette-years was stronger for women (OR, 1.8; 95% CI, 1.2-2.6, for a 400-U increase in cigarette-years) than for men (OR, 1.2; 95% CI, 0.9-1.6, for a 700-U increase in cigarette-years).
CONCLUSION: Smoking is associated with the clinical severity of psoriasis and highlights the importance of smoking cessation in patients with psoriasis.

Entities:  

Mesh:

Year:  2005        PMID: 16365261     DOI: 10.1001/archderm.141.12.1580

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  47 in total

1.  Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Authors:  R M Fernandez-Torres; S Paradela; E Fonseca
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

Review 2.  Clinical and histologic diagnostic guidelines for psoriasis: a critical review.

Authors:  Mary Ann N Johnson; April W Armstrong
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 3.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

4.  Smoking and risk of incident psoriatic arthritis in US women.

Authors:  Wenqing Li; Jiali Han; Abrar A Qureshi
Journal:  Ann Rheum Dis       Date:  2011-11-08       Impact factor: 19.103

5.  Smoking and the risk of psoriasis in women: Nurses' Health Study II.

Authors:  Arathi R Setty; Gary Curhan; Hyon K Choi
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

6.  Can nicotine use alleviate symptoms of psoriasis?

Authors:  John Staples; Douglas Klein
Journal:  Can Fam Physician       Date:  2012-04       Impact factor: 3.275

Review 7.  [Comorbidities and psoriasis. Impact on clinical practice].

Authors:  S Gerdes; U Mrowietz
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

8.  Evaluate the effect of cadmium on levels of zinc in scalp hair and blood samples of smoker and nonsmoker psoriatic patients at different stage.

Authors:  Suraya Samejo; Atif G Kazi; Hassan I Afridi; Tasneem G Kazi
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-04       Impact factor: 4.223

Review 9.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

10.  Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.

Authors:  Charles G Helmick; Hyewon Lee-Han; Shawn C Hirsch; Tiffany L Baird; Christopher L Bartlett
Journal:  Am J Prev Med       Date:  2014-04-18       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.